Skip to main content
Log in

Competitive and noncompetitive N-methyl-D-aspartate antagonists protect dopaminergic and serotonergic neurotoxicity produced by methamphetamine in various brain regions

  • Full Papers
  • Published:
Journal of Neural Transmission / General Section JNT Aims and scope Submit manuscript

Summary

Protective effects of NMDA antagonists on dopaminergic and serotonergic neurotoxicity produced by methamphetamine (MA) were examined. Four injections of MA (7.5 mg/kg, s.c., at 2 h intervals) caused significant decrements (40–60% of control values) in levels of dopamine (DA) and its metabolites in the rat striatum and levels of serotonin (5-HT) and its metabolite in the medial prefrontal cortex, nucleus accumbens, striatum, anterior hypothalamus, amygdala and hippocampus. These decreases in DA, 5-HT and their metabolites were prevented by pretreatment with MK-801, a noncompetitive N-methyl-D-aspartate (NMDA) antagonist, or D-CPP-ene (SDZ EAA 494), a competitive NMDA antagonist. The results suggest that NMDA receptors play a role for MA-induced serotonergic damage in various brain regions as well as dopaminergic damage in the striatum.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bakhit C, Morgan ME, Peat MA, Gibb JW (1981) Long-term effects of methamphetamine on the synthesis and metabolism of 5-hydroxytryptamine in various regions of the rat brain. Neuropharmacology 20: 1135–1140

    Google Scholar 

  • Bowery NG, Wong EHF, Hudson AL (1988) Quantitative autoradiography of [3 H]-MK-801 binding sites in mammalian brain. Br J Pharmacol 93: 944–954

    Google Scholar 

  • Buening MK, Gibb JW (1974) Influence of methamphetamine and neuroleptic drugs on tyrosine hydroxylase activity. Eur J Pharmacol 26: 30–34

    Google Scholar 

  • Clow DW, Jhamanadas K (1989) Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen. J Pharmacol Exp Ther 248: 722–728

    Google Scholar 

  • Fagg GE, Foster AC (1983) Amino acid neurotransmitters and their pathways in the mammalian central nervous system. Neuroscience 9: 701–719

    Google Scholar 

  • Green AR, De Souza RJ, Williams JL, Murray TK, Cross AJ (1992) The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole. Neuropharmacology 31: 315–321

    Google Scholar 

  • Hotchkiss AJ, Gibb JW (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J Pharmacol Exp Ther 214: 257–262

    Google Scholar 

  • Johnson M, Stone DM, Hanson GR, Gibb JW (1987) Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system. Eur J Pharmacol 135: 231–234

    Google Scholar 

  • Johnson M, Hanson GR, Gibb JW (1989) Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog. Eur J Pharmacol 165: 315–318

    Google Scholar 

  • Jones SM, Snell LD, Johnson KM (1987) Inhibition by phencyclidine of excitatory amino acid-stimulated release of neurotransmitter in the nucleus accumbens. Neuropharmacology 26: 173–179

    Google Scholar 

  • Krebs MO, Desce JM, Kernel ML, Gauchy C, Godeheu G, Cheramy A, Glowinski J (1991) Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J Neurochem 56: 81–85

    Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275

    Google Scholar 

  • Monaghan DT, Cotman CW (1985) Distribution of N-methyl-D-aspartate-sensitive L-[3 H] glutamate-binding sites in rat brain. J Neurosci 5: 2909–2919

    Google Scholar 

  • Morgan ME, Gibb JW (1980) Short-term and long-term effects of methamphetamine on biogenic amine metabolism in extra-striatal dopaminergic nuclei. Neuropharmacology 19: 989–995

    Google Scholar 

  • Ohmori T, Koyama T, Yamashita I (1991) Effects of N-methyl-D-aspartate and related agents on dopamine release from superfused slices of rat striatum. In: Kameyama T, Nabeshima T, Domino EF (eds) NMDA receptor related agents: biochemistry, pharmacology, and behavior. NPP Books, Ann Arbor MI, pp 129–139

    Google Scholar 

  • Ohmori T, Nakamura F, Koyama T, Yamashita I (1992) Amygdala kinding does not alter the N-methyl-D-aspartate receptor-channel complex which modulates dopamine release in the rat striatum and amygdala. Brain Res 587: 257–262

    Google Scholar 

  • Palkovits M, Brounstein MJ (1988) Maps and guide to microdissection of the rat brain. Elsevier, New York

    Google Scholar 

  • Ricaurte GA, Schuster CR, Seiden LS (1980) Long-term effects of repeated methamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional sutdy. Brain Res 193: 153–163

    Google Scholar 

  • Schmidt CJ, Ritter JK, Sonsalla PK, Hanson GR, Gibb JW (1985) Role of dopamine in the neurotoxic effects of methamphetamine. J Pharmacol Exp Ther 233: 539–544

    Google Scholar 

  • Seiden LS, Fischman MW, Schuster CR (1975/76) Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend 1: 215–219

    Google Scholar 

  • Snell LD, Johnson KM (1986) Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. J Pharmacol Exp Ther 238: 938–946

    Google Scholar 

  • Sonsalla PK, Gibb JW, Hanson GR (1986) Roles of D 1 and D 2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems. J Pharmacol Exp Ther 238: 932–937

    Google Scholar 

  • Sonsalla PK, Nicklas WJ, Heikkila RE (1989) Role for excitatory amino acids in meth-amphetamine-induced nigrostriatal dopaminergic toxicity. Science 243: 398–400

    Google Scholar 

  • Sonsalla PK, Riordan DE, Heikkila RE (1991) Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J Pharmacol Exp Ther 256: 506–512

    Google Scholar 

  • Weihmuller FB, O'Dell SJ, Marshall JF (1992) MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow. Synapse 11: 155–163

    Google Scholar 

  • Yamamoto BK, Nash JF (1991) Methamphetamine neurotoxicity and striatal glutamate release. Soc Neurosci Abstr 17: 1429

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohmori, T., Koyama, T., Muraki, A. et al. Competitive and noncompetitive N-methyl-D-aspartate antagonists protect dopaminergic and serotonergic neurotoxicity produced by methamphetamine in various brain regions. J. Neural Transmission 92, 97–106 (1993). https://doi.org/10.1007/BF01244869

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01244869

Keywords

Navigation